GSK plans six new product filings in 2004.

التفاصيل البيبلوغرافية
العنوان: GSK plans six new product filings in 2004.
المصدر: Manufacturing Chemist. Jan2004, Vol. 75 Issue 1, p13-13. 2/5p.
مصطلحات موضوعية: *PHARMACEUTICAL industry, DRUGS, OPIOIDS, DIPHOSPHONATES, PHOSPHONIC acids
الشركة/الكيان: GLAXOSMITHKLINE
مستخلص: Lists the potential new products that GlaxoSmithKline plans to file in 2004. Alvimopan, a peripherally acting mu-opioid receptor antagonist; Boniva/Bonviva, a biphosphonate for osteoporosis; Solifenacin succinate.
قاعدة البيانات: Business Source Index